Global Neurotoxin Market Price 2024, Forecast To 2033
8 Mar, 2024
The neurotoxin market has witnessed rapid expansion, growing from $6.74 billion in 2023 to $7.43 billion in 2024, with a CAGR of 10.2%. This growth is driven by factors such as expanding applications in neurology and continued demand for aesthetic procedures. Projected to reach $11.14 billion by 2028, with a CAGR of 10.7%, this growth will be fueled by innovation in formulations and rising consumer awareness.
Global Neurotoxin Market Key Driver
The surge in cosmetic procedures aimed at enhancing appearance is anticipated to drive the neurotoxin market's growth. These procedures, influenced by societal and cultural factors, utilize neurotoxins to relax muscles and reduce wrinkles. For example, a survey conducted by the American Society of Plastic Surgeons revealed a significant increase in demand for cosmetic procedures, with three-quarters of plastic surgeons reporting heightened interest. Additionally, 30% of these professionals noted a doubling in their cosmetic procedure businesses. Thus, the surge in cosmetic interventions is fueling the neurotoxin market's expansion.
Get A Free Sample Of The Global Neurotoxin Market ReportGlobal Neurotoxin Market Segments
The neurotoxin market covered in this report is segmented –
1) Product Type:Botox, Dysport, Xeomin, Other Products
2) Application:Therapeutic, Aesthetic
3) End User:Hospitals, Specialty Clinics, Dermatology Clinics, Other End Users
By Geography: The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
North America was the largest region in the neurotoxin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Major Neurotoxin Industry Players
AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals; Merz Pharma GmbH & Co KGaA; Hugel Inc.; Evolus Inc.; Medytox Inc.; Croma-Pharma GmbH; Revance Therapeutics Inc.; US WorldMeds; Gufic Biosciences Ltd.; Hironic Co. Ltd.; Allergan; List Biological Laboratories; Lanzhou Institute of Biological Products Co. Ltd.; Solstice Neurosciences; Sinclair Pharma; Vida Aesthetics; Aquavit Holdings LLC; PharmaResearch Products Co.Ltd; Entod Pharmaceuticals; Object Pharma Inc.; Eisai Co. Ltd.
Get The Full Global Neurotoxin Market Report
Neurotoxin Market Overview
Neurotoxin is a substance that is specifically toxic to nerve cells (neurons) or the nervous system. They work by inhibiting neuron cellular processes.